nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CHRM2—Dimenhydrinate—atopic dermatitis	0.0849	0.208	CbGbCtD
Tolterodine—Bromodiphenhydramine—Dimenhydrinate—atopic dermatitis	0.0738	0.149	CrCrCtD
Tolterodine—KCNH2—Loratadine—atopic dermatitis	0.0642	0.157	CbGbCtD
Tolterodine—Dexbrompheniramine—Diphenhydramine—atopic dermatitis	0.0623	0.126	CrCrCtD
Tolterodine—Brompheniramine—Diphenhydramine—atopic dermatitis	0.0623	0.126	CrCrCtD
Tolterodine—Orphenadrine—Dimenhydrinate—atopic dermatitis	0.058	0.117	CrCrCtD
Tolterodine—Phenprocoumon—Diphenhydramine—atopic dermatitis	0.0551	0.111	CrCrCtD
Tolterodine—Chlorphenamine—Diphenhydramine—atopic dermatitis	0.0495	0.1	CrCrCtD
Tolterodine—CHRM2—Diphenhydramine—atopic dermatitis	0.0414	0.102	CbGbCtD
Tolterodine—Atomoxetine—Diphenhydramine—atopic dermatitis	0.0375	0.0757	CrCrCtD
Tolterodine—Bromodiphenhydramine—Diphenhydramine—atopic dermatitis	0.035	0.0707	CrCrCtD
Tolterodine—Pheniramine—Diphenhydramine—atopic dermatitis	0.0343	0.0692	CrCrCtD
Tolterodine—Orphenadrine—Diphenhydramine—atopic dermatitis	0.0275	0.0556	CrCrCtD
Tolterodine—CYP3A4—Pimecrolimus—atopic dermatitis	0.0221	0.0541	CbGbCtD
Tolterodine—CYP2C19—Loratadine—atopic dermatitis	0.0199	0.0487	CbGbCtD
Tolterodine—CYP2C19—Diphenhydramine—atopic dermatitis	0.0199	0.0487	CbGbCtD
Tolterodine—CYP2C9—Loratadine—atopic dermatitis	0.0165	0.0405	CbGbCtD
Tolterodine—CYP2C9—Diphenhydramine—atopic dermatitis	0.0165	0.0405	CbGbCtD
Tolterodine—CYP2D6—Diphenhydramine—atopic dermatitis	0.0151	0.037	CbGbCtD
Tolterodine—CYP2D6—Loratadine—atopic dermatitis	0.0151	0.037	CbGbCtD
Tolterodine—CYP3A4—Tacrolimus—atopic dermatitis	0.0131	0.0322	CbGbCtD
Tolterodine—CYP2C19—Prednisone—atopic dermatitis	0.011	0.027	CbGbCtD
Tolterodine—CYP3A4—Loratadine—atopic dermatitis	0.00961	0.0236	CbGbCtD
Tolterodine—CYP3A4—Methylprednisolone—atopic dermatitis	0.00879	0.0215	CbGbCtD
Tolterodine—CYP2C19—Dexamethasone—atopic dermatitis	0.00687	0.0169	CbGbCtD
Tolterodine—CYP3A4—Triamcinolone—atopic dermatitis	0.00666	0.0163	CbGbCtD
Tolterodine—CYP2C9—Dexamethasone—atopic dermatitis	0.00572	0.014	CbGbCtD
Tolterodine—CYP3A4—Betamethasone—atopic dermatitis	0.00571	0.014	CbGbCtD
Tolterodine—CYP3A4—Prednisolone—atopic dermatitis	0.00564	0.0138	CbGbCtD
Tolterodine—CYP3A4—Hydrocortisone—atopic dermatitis	0.00534	0.0131	CbGbCtD
Tolterodine—CYP3A4—Prednisone—atopic dermatitis	0.00532	0.0131	CbGbCtD
Tolterodine—CYP2D6—Dexamethasone—atopic dermatitis	0.00523	0.0128	CbGbCtD
Tolterodine—CYP3A4—Dexamethasone—atopic dermatitis	0.00332	0.00815	CbGbCtD
Tolterodine—Dry eye—Hydrocortisone—atopic dermatitis	0.000399	0.00436	CcSEcCtD
Tolterodine—Weight increased—Tacrolimus—atopic dermatitis	0.000396	0.00432	CcSEcCtD
Tolterodine—Palpitations—Loratadine—atopic dermatitis	0.000392	0.00428	CcSEcCtD
Tolterodine—Pain—Pimecrolimus—atopic dermatitis	0.000389	0.00424	CcSEcCtD
Tolterodine—Constipation—Pimecrolimus—atopic dermatitis	0.000389	0.00424	CcSEcCtD
Tolterodine—Feeling abnormal—Diphenhydramine—atopic dermatitis	0.000387	0.00423	CcSEcCtD
Tolterodine—Feeling abnormal—Dimenhydrinate—atopic dermatitis	0.000387	0.00423	CcSEcCtD
Tolterodine—Hypersensitivity—Fluocinonide—atopic dermatitis	0.000384	0.00419	CcSEcCtD
Tolterodine—Chest pain—Loratadine—atopic dermatitis	0.000378	0.00412	CcSEcCtD
Tolterodine—Urinary tract infection—Tacrolimus—atopic dermatitis	0.000377	0.00412	CcSEcCtD
Tolterodine—Gastrointestinal pain—Pimecrolimus—atopic dermatitis	0.000372	0.00406	CcSEcCtD
Tolterodine—Dry mouth—Loratadine—atopic dermatitis	0.000369	0.00403	CcSEcCtD
Tolterodine—Sinusitis—Tacrolimus—atopic dermatitis	0.000364	0.00397	CcSEcCtD
Tolterodine—Anaphylactic shock—Loratadine—atopic dermatitis	0.000362	0.00395	CcSEcCtD
Tolterodine—Abdominal pain—Pimecrolimus—atopic dermatitis	0.000359	0.00392	CcSEcCtD
Tolterodine—Vertigo—Fluocinolone Acetonide—atopic dermatitis	0.000358	0.00391	CcSEcCtD
Tolterodine—Tachycardia—Loratadine—atopic dermatitis	0.000353	0.00386	CcSEcCtD
Tolterodine—Angioedema—Mometasone—atopic dermatitis	0.000348	0.0038	CcSEcCtD
Tolterodine—Hallucination—Tacrolimus—atopic dermatitis	0.000346	0.00378	CcSEcCtD
Tolterodine—Dizziness—Fluocinonide—atopic dermatitis	0.000345	0.00376	CcSEcCtD
Tolterodine—Oedema peripheral—Tacrolimus—atopic dermatitis	0.000343	0.00374	CcSEcCtD
Tolterodine—Dry eye—Betamethasone—atopic dermatitis	0.000341	0.00373	CcSEcCtD
Tolterodine—Dry eye—Dexamethasone—atopic dermatitis	0.000341	0.00373	CcSEcCtD
Tolterodine—Arthralgia—Fluocinolone Acetonide—atopic dermatitis	0.00034	0.00371	CcSEcCtD
Tolterodine—Asthenia—Dimenhydrinate—atopic dermatitis	0.000337	0.00368	CcSEcCtD
Tolterodine—Asthenia—Diphenhydramine—atopic dermatitis	0.000337	0.00368	CcSEcCtD
Tolterodine—Visual impairment—Tacrolimus—atopic dermatitis	0.000336	0.00366	CcSEcCtD
Tolterodine—Hypersensitivity—Pimecrolimus—atopic dermatitis	0.000335	0.00366	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Prednisolone—atopic dermatitis	0.000332	0.00363	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Loratadine—atopic dermatitis	0.00033	0.0036	CcSEcCtD
Tolterodine—Headache—Fluocinonide—atopic dermatitis	0.000327	0.00357	CcSEcCtD
Tolterodine—Oedema—Fluocinolone Acetonide—atopic dermatitis	0.000325	0.00355	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Hydrocortisone—atopic dermatitis	0.000324	0.00354	CcSEcCtD
Tolterodine—Chest pain—Mometasone—atopic dermatitis	0.000324	0.00354	CcSEcCtD
Tolterodine—Arthralgia—Mometasone—atopic dermatitis	0.000324	0.00354	CcSEcCtD
Tolterodine—Infection—Fluocinolone Acetonide—atopic dermatitis	0.000323	0.00353	CcSEcCtD
Tolterodine—Flushing—Tacrolimus—atopic dermatitis	0.000323	0.00353	CcSEcCtD
Tolterodine—Somnolence—Loratadine—atopic dermatitis	0.000322	0.00351	CcSEcCtD
Tolterodine—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.000322	0.00351	CcSEcCtD
Tolterodine—Diarrhoea—Diphenhydramine—atopic dermatitis	0.000322	0.00351	CcSEcCtD
Tolterodine—Dyspepsia—Loratadine—atopic dermatitis	0.000319	0.00348	CcSEcCtD
Tolterodine—Dry mouth—Mometasone—atopic dermatitis	0.000317	0.00346	CcSEcCtD
Tolterodine—Fatigue—Loratadine—atopic dermatitis	0.000312	0.00341	CcSEcCtD
Tolterodine—Diarrhoea—Pimecrolimus—atopic dermatitis	0.000311	0.0034	CcSEcCtD
Tolterodine—Dizziness—Dimenhydrinate—atopic dermatitis	0.000311	0.00339	CcSEcCtD
Tolterodine—Dizziness—Diphenhydramine—atopic dermatitis	0.000311	0.00339	CcSEcCtD
Tolterodine—Anaphylactic shock—Mometasone—atopic dermatitis	0.000311	0.00339	CcSEcCtD
Tolterodine—Constipation—Loratadine—atopic dermatitis	0.00031	0.00338	CcSEcCtD
Tolterodine—Pain—Loratadine—atopic dermatitis	0.00031	0.00338	CcSEcCtD
Tolterodine—Infection—Mometasone—atopic dermatitis	0.000309	0.00337	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Triamcinolone—atopic dermatitis	0.000305	0.00333	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Methylprednisolone—atopic dermatitis	0.000305	0.00333	CcSEcCtD
Tolterodine—Flatulence—Tacrolimus—atopic dermatitis	0.000299	0.00326	CcSEcCtD
Tolterodine—Feeling abnormal—Loratadine—atopic dermatitis	0.000298	0.00326	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Fluocinolone Acetonide—atopic dermatitis	0.000297	0.00324	CcSEcCtD
Tolterodine—Gastrointestinal pain—Loratadine—atopic dermatitis	0.000296	0.00323	CcSEcCtD
Tolterodine—Dry skin—Prednisolone—atopic dermatitis	0.000295	0.00322	CcSEcCtD
Tolterodine—Headache—Dimenhydrinate—atopic dermatitis	0.000295	0.00322	CcSEcCtD
Tolterodine—Headache—Diphenhydramine—atopic dermatitis	0.000295	0.00322	CcSEcCtD
Tolterodine—Dry skin—Hydrocortisone—atopic dermatitis	0.000288	0.00314	CcSEcCtD
Tolterodine—Abdominal pain—Loratadine—atopic dermatitis	0.000286	0.00312	CcSEcCtD
Tolterodine—Headache—Pimecrolimus—atopic dermatitis	0.000285	0.00311	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Mometasone—atopic dermatitis	0.000283	0.00309	CcSEcCtD
Tolterodine—Pain—Fluocinolone Acetonide—atopic dermatitis	0.000278	0.00304	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Dexamethasone—atopic dermatitis	0.000277	0.00303	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Betamethasone—atopic dermatitis	0.000277	0.00303	CcSEcCtD
Tolterodine—Dyspepsia—Mometasone—atopic dermatitis	0.000274	0.00299	CcSEcCtD
Tolterodine—Vertigo—Tacrolimus—atopic dermatitis	0.000272	0.00297	CcSEcCtD
Tolterodine—Fatigue—Mometasone—atopic dermatitis	0.000268	0.00292	CcSEcCtD
Tolterodine—Palpitations—Tacrolimus—atopic dermatitis	0.000268	0.00292	CcSEcCtD
Tolterodine—Pain—Mometasone—atopic dermatitis	0.000266	0.0029	CcSEcCtD
Tolterodine—Asthenia—Loratadine—atopic dermatitis	0.00026	0.00284	CcSEcCtD
Tolterodine—Arthralgia—Tacrolimus—atopic dermatitis	0.000258	0.00282	CcSEcCtD
Tolterodine—Chest pain—Tacrolimus—atopic dermatitis	0.000258	0.00282	CcSEcCtD
Tolterodine—Anxiety—Tacrolimus—atopic dermatitis	0.000257	0.00281	CcSEcCtD
Tolterodine—Gastrointestinal pain—Mometasone—atopic dermatitis	0.000254	0.00277	CcSEcCtD
Tolterodine—Weight increased—Prednisolone—atopic dermatitis	0.000253	0.00276	CcSEcCtD
Tolterodine—Dry mouth—Tacrolimus—atopic dermatitis	0.000252	0.00275	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Hydrocortisone—atopic dermatitis	0.000252	0.00275	CcSEcCtD
Tolterodine—Confusional state—Tacrolimus—atopic dermatitis	0.000249	0.00272	CcSEcCtD
Tolterodine—Diarrhoea—Loratadine—atopic dermatitis	0.000248	0.0027	CcSEcCtD
Tolterodine—Anaphylactic shock—Tacrolimus—atopic dermatitis	0.000247	0.0027	CcSEcCtD
Tolterodine—Oedema—Tacrolimus—atopic dermatitis	0.000247	0.0027	CcSEcCtD
Tolterodine—Weight increased—Hydrocortisone—atopic dermatitis	0.000247	0.0027	CcSEcCtD
Tolterodine—Dry skin—Betamethasone—atopic dermatitis	0.000246	0.00268	CcSEcCtD
Tolterodine—Dry skin—Dexamethasone—atopic dermatitis	0.000246	0.00268	CcSEcCtD
Tolterodine—Infection—Tacrolimus—atopic dermatitis	0.000246	0.00268	CcSEcCtD
Tolterodine—Bronchitis—Triamcinolone—atopic dermatitis	0.000246	0.00268	CcSEcCtD
Tolterodine—Abdominal pain—Mometasone—atopic dermatitis	0.000246	0.00268	CcSEcCtD
Tolterodine—Tachycardia—Tacrolimus—atopic dermatitis	0.000241	0.00264	CcSEcCtD
Tolterodine—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.00024	0.00262	CcSEcCtD
Tolterodine—Dizziness—Loratadine—atopic dermatitis	0.000239	0.00261	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Triamcinolone—atopic dermatitis	0.000237	0.00259	CcSEcCtD
Tolterodine—Weight increased—Triamcinolone—atopic dermatitis	0.000233	0.00254	CcSEcCtD
Tolterodine—Weight increased—Methylprednisolone—atopic dermatitis	0.000232	0.00253	CcSEcCtD
Tolterodine—Headache—Loratadine—atopic dermatitis	0.000227	0.00248	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	0.000225	0.00246	CcSEcCtD
Tolterodine—Asthenia—Mometasone—atopic dermatitis	0.000223	0.00243	CcSEcCtD
Tolterodine—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000223	0.00243	CcSEcCtD
Tolterodine—Somnolence—Tacrolimus—atopic dermatitis	0.00022	0.0024	CcSEcCtD
Tolterodine—Dyspepsia—Tacrolimus—atopic dermatitis	0.000218	0.00238	CcSEcCtD
Tolterodine—Hallucination—Hydrocortisone—atopic dermatitis	0.000216	0.00236	CcSEcCtD
Tolterodine—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000215	0.00235	CcSEcCtD
Tolterodine—Visual impairment—Prednisolone—atopic dermatitis	0.000214	0.00234	CcSEcCtD
Tolterodine—Dry skin—Prednisone—atopic dermatitis	0.000214	0.00234	CcSEcCtD
Tolterodine—Fatigue—Tacrolimus—atopic dermatitis	0.000213	0.00233	CcSEcCtD
Tolterodine—Diarrhoea—Mometasone—atopic dermatitis	0.000213	0.00232	CcSEcCtD
Tolterodine—Pain—Tacrolimus—atopic dermatitis	0.000212	0.00231	CcSEcCtD
Tolterodine—Constipation—Tacrolimus—atopic dermatitis	0.000212	0.00231	CcSEcCtD
Tolterodine—Weight increased—Betamethasone—atopic dermatitis	0.000211	0.0023	CcSEcCtD
Tolterodine—Weight increased—Dexamethasone—atopic dermatitis	0.000211	0.0023	CcSEcCtD
Tolterodine—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000204	0.00223	CcSEcCtD
Tolterodine—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000204	0.00223	CcSEcCtD
Tolterodine—Hallucination—Methylprednisolone—atopic dermatitis	0.000203	0.00222	CcSEcCtD
Tolterodine—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000202	0.00221	CcSEcCtD
Tolterodine—Visual impairment—Methylprednisolone—atopic dermatitis	0.000197	0.00215	CcSEcCtD
Tolterodine—Abdominal pain—Tacrolimus—atopic dermatitis	0.000196	0.00213	CcSEcCtD
Tolterodine—Headache—Mometasone—atopic dermatitis	0.000195	0.00213	CcSEcCtD
Tolterodine—Hallucination—Dexamethasone—atopic dermatitis	0.000185	0.00202	CcSEcCtD
Tolterodine—Hallucination—Betamethasone—atopic dermatitis	0.000185	0.00202	CcSEcCtD
Tolterodine—Weight increased—Prednisone—atopic dermatitis	0.000184	0.00201	CcSEcCtD
Tolterodine—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000182	0.00199	CcSEcCtD
Tolterodine—Visual impairment—Dexamethasone—atopic dermatitis	0.000179	0.00195	CcSEcCtD
Tolterodine—Visual impairment—Betamethasone—atopic dermatitis	0.000179	0.00195	CcSEcCtD
Tolterodine—Asthenia—Tacrolimus—atopic dermatitis	0.000177	0.00194	CcSEcCtD
Tolterodine—Angioedema—Prednisolone—atopic dermatitis	0.000177	0.00193	CcSEcCtD
Tolterodine—Vertigo—Prednisolone—atopic dermatitis	0.000174	0.0019	CcSEcCtD
Tolterodine—Angioedema—Hydrocortisone—atopic dermatitis	0.000173	0.00189	CcSEcCtD
Tolterodine—Vertigo—Hydrocortisone—atopic dermatitis	0.00017	0.00185	CcSEcCtD
Tolterodine—Diarrhoea—Tacrolimus—atopic dermatitis	0.000169	0.00185	CcSEcCtD
Tolterodine—Dizziness—Tacrolimus—atopic dermatitis	0.000164	0.00179	CcSEcCtD
Tolterodine—Angioedema—Triamcinolone—atopic dermatitis	0.000163	0.00178	CcSEcCtD
Tolterodine—Angioedema—Methylprednisolone—atopic dermatitis	0.000162	0.00177	CcSEcCtD
Tolterodine—Hallucination—Prednisone—atopic dermatitis	0.000161	0.00176	CcSEcCtD
Tolterodine—Anxiety—Hydrocortisone—atopic dermatitis	0.00016	0.00175	CcSEcCtD
Tolterodine—Vertigo—Triamcinolone—atopic dermatitis	0.00016	0.00175	CcSEcCtD
Tolterodine—Vertigo—Methylprednisolone—atopic dermatitis	0.00016	0.00174	CcSEcCtD
Tolterodine—Oedema—Prednisolone—atopic dermatitis	0.000158	0.00172	CcSEcCtD
Tolterodine—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000158	0.00172	CcSEcCtD
Tolterodine—Headache—Tacrolimus—atopic dermatitis	0.000155	0.00169	CcSEcCtD
Tolterodine—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000154	0.00168	CcSEcCtD
Tolterodine—Oedema—Hydrocortisone—atopic dermatitis	0.000154	0.00168	CcSEcCtD
Tolterodine—Tachycardia—Prednisolone—atopic dermatitis	0.000154	0.00168	CcSEcCtD
Tolterodine—Infection—Hydrocortisone—atopic dermatitis	0.000153	0.00167	CcSEcCtD
Tolterodine—Arthralgia—Methylprednisolone—atopic dermatitis	0.000151	0.00165	CcSEcCtD
Tolterodine—Anxiety—Methylprednisolone—atopic dermatitis	0.000151	0.00165	CcSEcCtD
Tolterodine—Tachycardia—Hydrocortisone—atopic dermatitis	0.000151	0.00164	CcSEcCtD
Tolterodine—Flushing—Prednisone—atopic dermatitis	0.00015	0.00164	CcSEcCtD
Tolterodine—Dry mouth—Triamcinolone—atopic dermatitis	0.000148	0.00162	CcSEcCtD
Tolterodine—Angioedema—Betamethasone—atopic dermatitis	0.000148	0.00161	CcSEcCtD
Tolterodine—Angioedema—Dexamethasone—atopic dermatitis	0.000148	0.00161	CcSEcCtD
Tolterodine—Confusional state—Methylprednisolone—atopic dermatitis	0.000146	0.0016	CcSEcCtD
Tolterodine—Oedema—Triamcinolone—atopic dermatitis	0.000145	0.00159	CcSEcCtD
Tolterodine—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000145	0.00159	CcSEcCtD
Tolterodine—Vertigo—Dexamethasone—atopic dermatitis	0.000145	0.00158	CcSEcCtD
Tolterodine—Vertigo—Betamethasone—atopic dermatitis	0.000145	0.00158	CcSEcCtD
Tolterodine—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000145	0.00158	CcSEcCtD
Tolterodine—Infection—Triamcinolone—atopic dermatitis	0.000144	0.00158	CcSEcCtD
Tolterodine—Infection—Methylprednisolone—atopic dermatitis	0.000144	0.00157	CcSEcCtD
Tolterodine—Tachycardia—Triamcinolone—atopic dermatitis	0.000142	0.00155	CcSEcCtD
Tolterodine—Tachycardia—Methylprednisolone—atopic dermatitis	0.000141	0.00154	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000141	0.00153	CcSEcCtD
Tolterodine—Anxiety—Betamethasone—atopic dermatitis	0.000137	0.0015	CcSEcCtD
Tolterodine—Anxiety—Dexamethasone—atopic dermatitis	0.000137	0.0015	CcSEcCtD
Tolterodine—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000136	0.00148	CcSEcCtD
Tolterodine—Pain—Prednisolone—atopic dermatitis	0.000135	0.00147	CcSEcCtD
Tolterodine—Fatigue—Hydrocortisone—atopic dermatitis	0.000133	0.00145	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000132	0.00144	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000132	0.00144	CcSEcCtD
Tolterodine—Pain—Hydrocortisone—atopic dermatitis	0.000132	0.00144	CcSEcCtD
Tolterodine—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000132	0.00144	CcSEcCtD
Tolterodine—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000132	0.00144	CcSEcCtD
Tolterodine—Oedema—Betamethasone—atopic dermatitis	0.000132	0.00144	CcSEcCtD
Tolterodine—Oedema—Dexamethasone—atopic dermatitis	0.000132	0.00144	CcSEcCtD
Tolterodine—Infection—Dexamethasone—atopic dermatitis	0.000131	0.00143	CcSEcCtD
Tolterodine—Infection—Betamethasone—atopic dermatitis	0.000131	0.00143	CcSEcCtD
Tolterodine—Feeling abnormal—Prednisolone—atopic dermatitis	0.00013	0.00142	CcSEcCtD
Tolterodine—Tachycardia—Betamethasone—atopic dermatitis	0.000129	0.0014	CcSEcCtD
Tolterodine—Tachycardia—Dexamethasone—atopic dermatitis	0.000129	0.0014	CcSEcCtD
Tolterodine—Angioedema—Prednisone—atopic dermatitis	0.000129	0.0014	CcSEcCtD
Tolterodine—Dyspepsia—Triamcinolone—atopic dermatitis	0.000128	0.0014	CcSEcCtD
Tolterodine—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000128	0.00139	CcSEcCtD
Tolterodine—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000127	0.00139	CcSEcCtD
Tolterodine—Vertigo—Prednisone—atopic dermatitis	0.000126	0.00138	CcSEcCtD
Tolterodine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000126	0.00138	CcSEcCtD
Tolterodine—Fatigue—Triamcinolone—atopic dermatitis	0.000125	0.00137	CcSEcCtD
Tolterodine—Fatigue—Methylprednisolone—atopic dermatitis	0.000125	0.00136	CcSEcCtD
Tolterodine—Pain—Triamcinolone—atopic dermatitis	0.000124	0.00136	CcSEcCtD
Tolterodine—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000122	0.00133	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.00012	0.00131	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.00012	0.00131	CcSEcCtD
Tolterodine—Arthralgia—Prednisone—atopic dermatitis	0.00012	0.00131	CcSEcCtD
Tolterodine—Feeling abnormal—Triamcinolone—atopic dermatitis	0.00012	0.00131	CcSEcCtD
Tolterodine—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000119	0.0013	CcSEcCtD
Tolterodine—Anxiety—Prednisone—atopic dermatitis	0.000119	0.0013	CcSEcCtD
Tolterodine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000119	0.00129	CcSEcCtD
Tolterodine—Hypersensitivity—Prednisolone—atopic dermatitis	0.000116	0.00127	CcSEcCtD
Tolterodine—Dyspepsia—Dexamethasone—atopic dermatitis	0.000116	0.00127	CcSEcCtD
Tolterodine—Dyspepsia—Betamethasone—atopic dermatitis	0.000116	0.00127	CcSEcCtD
Tolterodine—Anaphylactic shock—Prednisone—atopic dermatitis	0.000115	0.00125	CcSEcCtD
Tolterodine—Oedema—Prednisone—atopic dermatitis	0.000115	0.00125	CcSEcCtD
Tolterodine—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000115	0.00125	CcSEcCtD
Tolterodine—Infection—Prednisone—atopic dermatitis	0.000114	0.00125	CcSEcCtD
Tolterodine—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000114	0.00124	CcSEcCtD
Tolterodine—Fatigue—Betamethasone—atopic dermatitis	0.000114	0.00124	CcSEcCtD
Tolterodine—Fatigue—Dexamethasone—atopic dermatitis	0.000114	0.00124	CcSEcCtD
Tolterodine—Pain—Betamethasone—atopic dermatitis	0.000113	0.00123	CcSEcCtD
Tolterodine—Pain—Dexamethasone—atopic dermatitis	0.000113	0.00123	CcSEcCtD
Tolterodine—Tachycardia—Prednisone—atopic dermatitis	0.000112	0.00122	CcSEcCtD
Tolterodine—Asthenia—Hydrocortisone—atopic dermatitis	0.000111	0.00121	CcSEcCtD
Tolterodine—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000109	0.00119	CcSEcCtD
Tolterodine—Feeling abnormal—Betamethasone—atopic dermatitis	0.000109	0.00119	CcSEcCtD
Tolterodine—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000108	0.00118	CcSEcCtD
Tolterodine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000108	0.00118	CcSEcCtD
Tolterodine—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000107	0.00117	CcSEcCtD
Tolterodine—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000107	0.00117	CcSEcCtD
Tolterodine—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000106	0.00115	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000105	0.00114	CcSEcCtD
Tolterodine—Dizziness—Prednisolone—atopic dermatitis	0.000104	0.00114	CcSEcCtD
Tolterodine—Asthenia—Triamcinolone—atopic dermatitis	0.000104	0.00114	CcSEcCtD
Tolterodine—Abdominal pain—Betamethasone—atopic dermatitis	0.000104	0.00114	CcSEcCtD
Tolterodine—Abdominal pain—Dexamethasone—atopic dermatitis	0.000104	0.00114	CcSEcCtD
Tolterodine—Asthenia—Methylprednisolone—atopic dermatitis	0.000104	0.00114	CcSEcCtD
Tolterodine—Dizziness—Hydrocortisone—atopic dermatitis	0.000102	0.00111	CcSEcCtD
Tolterodine—Dyspepsia—Prednisone—atopic dermatitis	0.000101	0.0011	CcSEcCtD
Tolterodine—Diarrhoea—Methylprednisolone—atopic dermatitis	9.92e-05	0.00108	CcSEcCtD
Tolterodine—Fatigue—Prednisone—atopic dermatitis	9.9e-05	0.00108	CcSEcCtD
Tolterodine—Headache—Prednisolone—atopic dermatitis	9.9e-05	0.00108	CcSEcCtD
Tolterodine—Constipation—Prednisone—atopic dermatitis	9.82e-05	0.00107	CcSEcCtD
Tolterodine—Headache—Hydrocortisone—atopic dermatitis	9.67e-05	0.00106	CcSEcCtD
Tolterodine—Dizziness—Triamcinolone—atopic dermatitis	9.61e-05	0.00105	CcSEcCtD
Tolterodine—Dizziness—Methylprednisolone—atopic dermatitis	9.59e-05	0.00105	CcSEcCtD
Tolterodine—Feeling abnormal—Prednisone—atopic dermatitis	9.46e-05	0.00103	CcSEcCtD
Tolterodine—Asthenia—Dexamethasone—atopic dermatitis	9.46e-05	0.00103	CcSEcCtD
Tolterodine—Asthenia—Betamethasone—atopic dermatitis	9.46e-05	0.00103	CcSEcCtD
Tolterodine—Gastrointestinal pain—Prednisone—atopic dermatitis	9.39e-05	0.00102	CcSEcCtD
Tolterodine—Headache—Triamcinolone—atopic dermatitis	9.1e-05	0.000994	CcSEcCtD
Tolterodine—Headache—Methylprednisolone—atopic dermatitis	9.08e-05	0.000991	CcSEcCtD
Tolterodine—Abdominal pain—Prednisone—atopic dermatitis	9.08e-05	0.000991	CcSEcCtD
Tolterodine—Diarrhoea—Betamethasone—atopic dermatitis	9.02e-05	0.000985	CcSEcCtD
Tolterodine—Diarrhoea—Dexamethasone—atopic dermatitis	9.02e-05	0.000985	CcSEcCtD
Tolterodine—Dizziness—Dexamethasone—atopic dermatitis	8.72e-05	0.000952	CcSEcCtD
Tolterodine—Dizziness—Betamethasone—atopic dermatitis	8.72e-05	0.000952	CcSEcCtD
Tolterodine—Hypersensitivity—Prednisone—atopic dermatitis	8.46e-05	0.000923	CcSEcCtD
Tolterodine—Headache—Dexamethasone—atopic dermatitis	8.26e-05	0.000902	CcSEcCtD
Tolterodine—Headache—Betamethasone—atopic dermatitis	8.26e-05	0.000902	CcSEcCtD
Tolterodine—Asthenia—Prednisone—atopic dermatitis	8.24e-05	0.000899	CcSEcCtD
Tolterodine—Diarrhoea—Prednisone—atopic dermatitis	7.86e-05	0.000857	CcSEcCtD
Tolterodine—Dizziness—Prednisone—atopic dermatitis	7.59e-05	0.000829	CcSEcCtD
Tolterodine—Headache—Prednisone—atopic dermatitis	7.19e-05	0.000785	CcSEcCtD
Tolterodine—CHRM5—GPCR downstream signaling—TAC1—atopic dermatitis	9.2e-06	0.00171	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—NPS—atopic dermatitis	9.2e-06	0.00171	CbGpPWpGaD
Tolterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	9.14e-06	0.0017	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—CXCL10—atopic dermatitis	9.09e-06	0.00169	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—CXCL10—atopic dermatitis	9.06e-06	0.00168	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—CXCR3—atopic dermatitis	9.03e-06	0.00168	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—CXCL10—atopic dermatitis	8.97e-06	0.00167	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—IL5—atopic dermatitis	8.94e-06	0.00166	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CCL17—atopic dermatitis	8.8e-06	0.00163	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—NPS—atopic dermatitis	8.73e-06	0.00162	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—TAC1—atopic dermatitis	8.73e-06	0.00162	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—CXCR3—atopic dermatitis	8.56e-06	0.00159	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—IL5—atopic dermatitis	8.56e-06	0.00159	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CCL17—atopic dermatitis	8.43e-06	0.00157	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—NPS—atopic dermatitis	8.36e-06	0.00155	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—TAC1—atopic dermatitis	8.36e-06	0.00155	CbGpPWpGaD
Tolterodine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	8.3e-06	0.00154	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—CXCR3—atopic dermatitis	8.2e-06	0.00152	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—IL5—atopic dermatitis	8.11e-06	0.00151	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—CCL11—atopic dermatitis	8.1e-06	0.0015	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—CCL11—atopic dermatitis	8.07e-06	0.0015	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—CCL11—atopic dermatitis	8e-06	0.00148	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—FCER2—atopic dermatitis	7.99e-06	0.00148	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—FCER2—atopic dermatitis	7.96e-06	0.00148	CbGpPWpGaD
Tolterodine—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	7.95e-06	0.00148	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—FCER2—atopic dermatitis	7.88e-06	0.00146	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—KIF3A—atopic dermatitis	7.85e-06	0.00146	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—CCL5—atopic dermatitis	7.83e-06	0.00145	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—CCL5—atopic dermatitis	7.8e-06	0.00145	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—IL5—atopic dermatitis	7.77e-06	0.00144	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—CCL5—atopic dermatitis	7.72e-06	0.00143	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—CXCL10—atopic dermatitis	7.62e-06	0.00141	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—GLB1—atopic dermatitis	7.53e-06	0.0014	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—KIF3A—atopic dermatitis	7.51e-06	0.0014	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCL22—atopic dermatitis	7.43e-06	0.00138	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCL22—atopic dermatitis	7.4e-06	0.00137	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCL22—atopic dermatitis	7.33e-06	0.00136	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—CXCL10—atopic dermatitis	7.3e-06	0.00135	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—CCR3—atopic dermatitis	7.27e-06	0.00135	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—CCR3—atopic dermatitis	7.25e-06	0.00135	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—ADSL—atopic dermatitis	7.22e-06	0.00134	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—CCR3—atopic dermatitis	7.18e-06	0.00133	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CMA1—atopic dermatitis	7.1e-06	0.00132	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CCL11—atopic dermatitis	7.1e-06	0.00132	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—CCR5—atopic dermatitis	7.05e-06	0.00131	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—CCR5—atopic dermatitis	7.03e-06	0.00131	CbGpPWpGaD
Tolterodine—CHRM1—Circadian rythm related genes—MAPK8—atopic dermatitis	7.02e-06	0.0013	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—CCR5—atopic dermatitis	6.96e-06	0.00129	CbGpPWpGaD
Tolterodine—CHRM2—G alpha (i) signalling events—CXCL8—atopic dermatitis	6.95e-06	0.00129	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—CXCL10—atopic dermatitis	6.92e-06	0.00128	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CCL11—atopic dermatitis	6.8e-06	0.00126	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CMA1—atopic dermatitis	6.8e-06	0.00126	CbGpPWpGaD
Tolterodine—CHRM2—SIDS Susceptibility Pathways—TNF—atopic dermatitis	6.71e-06	0.00125	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—STAT6—atopic dermatitis	6.67e-06	0.00124	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—CXCL10—atopic dermatitis	6.63e-06	0.00123	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCL27—atopic dermatitis	6.62e-06	0.00123	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—CCR3—atopic dermatitis	6.6e-06	0.00123	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCL27—atopic dermatitis	6.6e-06	0.00123	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—CCR3—atopic dermatitis	6.58e-06	0.00122	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—CCL5—atopic dermatitis	6.56e-06	0.00122	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCL27—atopic dermatitis	6.53e-06	0.00121	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—CCR3—atopic dermatitis	6.52e-06	0.00121	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—NPS—atopic dermatitis	6.48e-06	0.0012	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—TAC1—atopic dermatitis	6.48e-06	0.0012	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—NPS—atopic dermatitis	6.46e-06	0.0012	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—TAC1—atopic dermatitis	6.46e-06	0.0012	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—NPS—atopic dermatitis	6.4e-06	0.00119	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—TAC1—atopic dermatitis	6.4e-06	0.00119	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—STAT6—atopic dermatitis	6.39e-06	0.00119	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	6.36e-06	0.00118	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—CXCR3—atopic dermatitis	6.34e-06	0.00118	CbGpPWpGaD
Tolterodine—CHRM4—GPCR ligand binding—CXCL8—atopic dermatitis	6.32e-06	0.00117	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—CCL5—atopic dermatitis	6.28e-06	0.00117	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—CXCR3—atopic dermatitis	6.27e-06	0.00117	CbGpPWpGaD
Tolterodine—CHRM5—GPCR ligand binding—CXCL8—atopic dermatitis	6.05e-06	0.00112	CbGpPWpGaD
Tolterodine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	6.03e-06	0.00112	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—IL5—atopic dermatitis	6.03e-06	0.00112	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—IL5—atopic dermatitis	6.01e-06	0.00112	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—CCL5—atopic dermatitis	5.96e-06	0.00111	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—IL5—atopic dermatitis	5.95e-06	0.0011	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCL17—atopic dermatitis	5.94e-06	0.0011	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCL17—atopic dermatitis	5.92e-06	0.0011	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—CCR5—atopic dermatitis	5.91e-06	0.0011	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—TAC1—atopic dermatitis	5.89e-06	0.00109	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—NPS—atopic dermatitis	5.89e-06	0.00109	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—TAC1—atopic dermatitis	5.87e-06	0.00109	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—NPS—atopic dermatitis	5.87e-06	0.00109	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCL17—atopic dermatitis	5.86e-06	0.00109	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—NPS—atopic dermatitis	5.81e-06	0.00108	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—TAC1—atopic dermatitis	5.81e-06	0.00108	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CCR3—atopic dermatitis	5.78e-06	0.00107	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—CXCR3—atopic dermatitis	5.77e-06	0.00107	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—CXCR3—atopic dermatitis	5.75e-06	0.00107	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—CCL5—atopic dermatitis	5.7e-06	0.00106	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—CXCR3—atopic dermatitis	5.7e-06	0.00106	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—CCR5—atopic dermatitis	5.66e-06	0.00105	CbGpPWpGaD
Tolterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	5.6e-06	0.00104	CbGpPWpGaD
Tolterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	5.58e-06	0.00104	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CCR3—atopic dermatitis	5.54e-06	0.00103	CbGpPWpGaD
Tolterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	5.53e-06	0.00103	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—IL5—atopic dermatitis	5.47e-06	0.00102	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—IL5—atopic dermatitis	5.45e-06	0.00101	CbGpPWpGaD
Tolterodine—CHRM2—SIDS Susceptibility Pathways—IL6—atopic dermatitis	5.42e-06	0.00101	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—IL5—atopic dermatitis	5.4e-06	0.001	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—CCR5—atopic dermatitis	5.37e-06	0.000996	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—KIF3A—atopic dermatitis	5.29e-06	0.000983	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—KIF3A—atopic dermatitis	5.27e-06	0.000979	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—KIF3A—atopic dermatitis	5.22e-06	0.00097	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—NPS—atopic dermatitis	5.16e-06	0.000958	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TAC1—atopic dermatitis	5.16e-06	0.000958	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—CCR5—atopic dermatitis	5.14e-06	0.000954	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	5.14e-06	0.000954	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—CXCL10—atopic dermatitis	5.12e-06	0.000951	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—CXCL10—atopic dermatitis	5.07e-06	0.000942	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CXCR3—atopic dermatitis	5.06e-06	0.000939	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—NPS—atopic dermatitis	4.94e-06	0.000917	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TAC1—atopic dermatitis	4.94e-06	0.000917	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GLB1—atopic dermatitis	4.89e-06	0.000909	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CXCR3—atopic dermatitis	4.84e-06	0.000899	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IL5—atopic dermatitis	4.79e-06	0.00089	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CMA1—atopic dermatitis	4.78e-06	0.000889	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCL11—atopic dermatitis	4.78e-06	0.000889	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCL11—atopic dermatitis	4.77e-06	0.000886	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CMA1—atopic dermatitis	4.77e-06	0.000886	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CMA1—atopic dermatitis	4.72e-06	0.000877	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCL11—atopic dermatitis	4.72e-06	0.000877	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ADSL—atopic dermatitis	4.69e-06	0.000871	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—CXCL10—atopic dermatitis	4.67e-06	0.000866	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—CXCL10—atopic dermatitis	4.65e-06	0.000864	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—CXCL10—atopic dermatitis	4.61e-06	0.000855	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IL5—atopic dermatitis	4.59e-06	0.000852	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GLB1—atopic dermatitis	4.5e-06	0.000836	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—STAT6—atopic dermatitis	4.5e-06	0.000835	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—STAT6—atopic dermatitis	4.48e-06	0.000833	CbGpPWpGaD
Tolterodine—CHRM1—Circadian rythm related genes—IL6—atopic dermatitis	4.48e-06	0.000832	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GLB1—atopic dermatitis	4.46e-06	0.000829	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—STAT6—atopic dermatitis	4.44e-06	0.000825	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—CCL5—atopic dermatitis	4.42e-06	0.000821	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—CCL5—atopic dermatitis	4.41e-06	0.000819	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—CCL5—atopic dermatitis	4.37e-06	0.000811	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ADSL—atopic dermatitis	4.31e-06	0.000801	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ADSL—atopic dermatitis	4.28e-06	0.000794	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—CXCL8—atopic dermatitis	4.26e-06	0.000792	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—CXCL8—atopic dermatitis	4.25e-06	0.000789	CbGpPWpGaD
Tolterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	4.25e-06	0.000789	CbGpPWpGaD
Tolterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	4.23e-06	0.000786	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—CXCL8—atopic dermatitis	4.21e-06	0.000781	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CXCL10—atopic dermatitis	4.09e-06	0.000759	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—CCL5—atopic dermatitis	4.02e-06	0.000746	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—CCL5—atopic dermatitis	4e-06	0.000743	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—CCR5—atopic dermatitis	3.98e-06	0.00074	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—CCR5—atopic dermatitis	3.97e-06	0.000738	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—CCL5—atopic dermatitis	3.96e-06	0.000736	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—CCR5—atopic dermatitis	3.93e-06	0.00073	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CXCL10—atopic dermatitis	3.91e-06	0.000727	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCR3—atopic dermatitis	3.9e-06	0.000724	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCR3—atopic dermatitis	3.89e-06	0.000722	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCR3—atopic dermatitis	3.85e-06	0.000715	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—CCR5—atopic dermatitis	3.62e-06	0.000672	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—CCR5—atopic dermatitis	3.61e-06	0.00067	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—CXCL8—atopic dermatitis	3.57e-06	0.000663	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—CCR5—atopic dermatitis	3.57e-06	0.000663	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.57e-06	0.000662	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CCL5—atopic dermatitis	3.52e-06	0.000653	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TAC1—atopic dermatitis	3.48e-06	0.000646	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NPS—atopic dermatitis	3.48e-06	0.000646	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NPS—atopic dermatitis	3.47e-06	0.000644	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TAC1—atopic dermatitis	3.47e-06	0.000644	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TAC1—atopic dermatitis	3.43e-06	0.000637	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NPS—atopic dermatitis	3.43e-06	0.000637	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—CXCL8—atopic dermatitis	3.42e-06	0.000635	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—IL2—atopic dermatitis	3.41e-06	0.000634	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CXCR3—atopic dermatitis	3.41e-06	0.000633	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CXCR3—atopic dermatitis	3.4e-06	0.000631	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CCL5—atopic dermatitis	3.37e-06	0.000626	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CXCR3—atopic dermatitis	3.37e-06	0.000625	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—IL2—atopic dermatitis	3.27e-06	0.000607	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—NGF—atopic dermatitis	3.26e-06	0.000605	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.25e-06	0.000604	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—CXCL8—atopic dermatitis	3.24e-06	0.000602	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL5—atopic dermatitis	3.23e-06	0.0006	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL5—atopic dermatitis	3.22e-06	0.000598	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL5—atopic dermatitis	3.19e-06	0.000593	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CCR5—atopic dermatitis	3.17e-06	0.000589	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—NGF—atopic dermatitis	3.12e-06	0.000579	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—CXCL8—atopic dermatitis	3.11e-06	0.000577	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—IL2—atopic dermatitis	3.1e-06	0.000576	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CCR5—atopic dermatitis	3.04e-06	0.000564	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—IL2—atopic dermatitis	2.97e-06	0.000551	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GLB1—atopic dermatitis	2.94e-06	0.000546	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ADSL—atopic dermatitis	2.82e-06	0.000524	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CXCL10—atopic dermatitis	2.76e-06	0.000512	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CXCL10—atopic dermatitis	2.75e-06	0.00051	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CXCL10—atopic dermatitis	2.72e-06	0.000505	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—NFKBIA—atopic dermatitis	2.69e-06	0.000499	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—NFKBIA—atopic dermatitis	2.57e-06	0.000478	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PPARA—atopic dermatitis	2.44e-06	0.000454	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	2.41e-06	0.000447	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—CXCL8—atopic dermatitis	2.4e-06	0.000446	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—CXCL8—atopic dermatitis	2.38e-06	0.000442	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCL5—atopic dermatitis	2.37e-06	0.000441	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCL5—atopic dermatitis	2.36e-06	0.000439	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCL5—atopic dermatitis	2.34e-06	0.000435	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—IL2—atopic dermatitis	2.3e-06	0.000427	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—IL2—atopic dermatitis	2.29e-06	0.000426	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—IL2—atopic dermatitis	2.27e-06	0.000422	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NGF—atopic dermatitis	2.2e-06	0.000408	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NGF—atopic dermatitis	2.19e-06	0.000407	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—CXCL8—atopic dermatitis	2.19e-06	0.000406	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—CXCL8—atopic dermatitis	2.18e-06	0.000405	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NGF—atopic dermatitis	2.17e-06	0.000403	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—CXCL8—atopic dermatitis	2.16e-06	0.000401	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCR5—atopic dermatitis	2.14e-06	0.000397	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCR5—atopic dermatitis	2.13e-06	0.000396	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCR5—atopic dermatitis	2.11e-06	0.000392	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—IL2—atopic dermatitis	2.09e-06	0.000388	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—IL2—atopic dermatitis	2.08e-06	0.000387	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—IL2—atopic dermatitis	2.06e-06	0.000383	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CXCL8—atopic dermatitis	1.92e-06	0.000356	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CXCL8—atopic dermatitis	1.84e-06	0.000341	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IL2—atopic dermatitis	1.83e-06	0.00034	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—IL6—atopic dermatitis	1.82e-06	0.000338	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NFKBIA—atopic dermatitis	1.81e-06	0.000336	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NFKBIA—atopic dermatitis	1.81e-06	0.000335	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NFKBIA—atopic dermatitis	1.79e-06	0.000332	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IL2—atopic dermatitis	1.75e-06	0.000326	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—IL6—atopic dermatitis	1.75e-06	0.000324	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MAPK8—atopic dermatitis	1.69e-06	0.000313	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MAPK8—atopic dermatitis	1.61e-06	0.0003	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PPARA—atopic dermatitis	1.59e-06	0.000295	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PPARA—atopic dermatitis	1.46e-06	0.000271	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PPARA—atopic dermatitis	1.45e-06	0.000269	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CXCL8—atopic dermatitis	1.29e-06	0.00024	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CXCL8—atopic dermatitis	1.29e-06	0.000239	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CXCL8—atopic dermatitis	1.28e-06	0.000237	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL2—atopic dermatitis	1.23e-06	0.000229	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL2—atopic dermatitis	1.23e-06	0.000229	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—IL6—atopic dermatitis	1.23e-06	0.000228	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—IL6—atopic dermatitis	1.22e-06	0.000227	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL2—atopic dermatitis	1.22e-06	0.000226	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—IL6—atopic dermatitis	1.21e-06	0.000225	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MAPK8—atopic dermatitis	1.14e-06	0.000211	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MAPK8—atopic dermatitis	1.13e-06	0.00021	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MAPK8—atopic dermatitis	1.12e-06	0.000208	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IL6—atopic dermatitis	1.08e-06	0.0002	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IL6—atopic dermatitis	1.03e-06	0.000191	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PPARA—atopic dermatitis	9.55e-07	0.000177	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL6—atopic dermatitis	7.26e-07	0.000135	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL6—atopic dermatitis	7.24e-07	0.000134	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL6—atopic dermatitis	7.16e-07	0.000133	CbGpPWpGaD
